MARK J. RUBASH - 21 Apr 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role
Director
Signature
By: Donna Spinola For: Rubash, Mark J.
Issuer symbol
ISRG
Transactions as of
21 Apr 2023
Net transactions value
-$1,288,827
Form type
4
Filing time
24 Apr 2023, 19:51:05 UTC
Previous filing
31 May 2022
Next filing
28 Apr 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $78,694 +460 +3.1% $171.07 15,460 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $137,052 -460 -3% $297.94 15,000 21 Apr 2023 Direct F1, F2
transaction ISRG Common Stock Options Exercise $78,694 +460 +3.1% $171.07 15,460 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $137,047 -460 -3% $297.93 15,000 21 Apr 2023 Direct F1, F3
transaction ISRG Common Stock Options Exercise $78,694 +460 +3.1% $171.07 15,460 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $137,054 -460 -3% $297.94 15,000 21 Apr 2023 Direct F1, F4
transaction ISRG Common Stock Options Exercise $39,347 +230 +1.5% $171.07 15,230 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $68,516 -230 -1.5% $297.89 15,000 21 Apr 2023 Direct F1, F5
transaction ISRG Common Stock Options Exercise $81,464 +472 +3.1% $172.59 15,472 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $140,628 -472 -3.1% $297.94 15,000 21 Apr 2023 Direct F1, F2
transaction ISRG Common Stock Options Exercise $81,464 +472 +3.1% $172.59 15,472 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $140,622 -472 -3.1% $297.93 15,000 21 Apr 2023 Direct F1, F3
transaction ISRG Common Stock Options Exercise $81,464 +472 +3.1% $172.59 15,472 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $140,630 -472 -3.1% $297.94 15,000 21 Apr 2023 Direct F1, F4
transaction ISRG Common Stock Options Exercise $40,559 +235 +1.6% $172.59 15,235 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $70,005 -235 -1.5% $297.89 15,000 21 Apr 2023 Direct F1, F5
transaction ISRG Common Stock Options Exercise $92,234 +598 +4% $154.24 15,598 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $178,168 -598 -3.8% $297.94 15,000 21 Apr 2023 Direct F1, F2
transaction ISRG Common Stock Options Exercise $92,234 +598 +4% $154.24 15,598 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $178,161 -598 -3.8% $297.93 15,000 21 Apr 2023 Direct F1, F3
transaction ISRG Common Stock Options Exercise $92,234 +598 +4% $154.24 15,598 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $178,171 -598 -3.8% $297.94 15,000 21 Apr 2023 Direct F1, F4
transaction ISRG Common Stock Options Exercise $46,117 +299 +2% $154.24 15,299 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $89,070 -299 -2% $297.89 15,000 21 Apr 2023 Direct F1, F5
transaction ISRG Common Stock Options Exercise $83,888 +927 +6.2% $90.49 15,927 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $276,191 -927 -5.8% $297.94 15,000 21 Apr 2023 Direct F1, F2
transaction ISRG Common Stock Options Exercise $83,888 +927 +6.2% $90.49 15,927 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $276,179 -927 -5.8% $297.93 15,000 21 Apr 2023 Direct F1, F3
transaction ISRG Common Stock Options Exercise $83,888 +927 +6.2% $90.49 15,927 21 Apr 2023 Direct F1
transaction ISRG Common Stock Sale $276,194 -927 -5.8% $297.94 15,000 21 Apr 2023 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on February 1, 2024.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.27 as follows: 638 shares sold at $296.60 to $297.49; 1,768 shares sold at $297.73 to $298.69; and 400 shares sold at $298.74 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.62 to $299.27 as follows: 638 shares sold at $296.62 to $297.49; 1,718 shares sold at $297.68 to $298.67; and 450 shares sold at $298.69 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.60 to $299.28 as follows: 638 shares sold at $296.60 to $297.51; 1,768 shares sold at $297.72 to $298.69; and 400 shares sold at $298.74 to $299.28. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.45 to $299.15 as follows: 275 shares sold at $296.45 to $297.41; 888 shares sold at $297.48 to $298.48; and 237 shares sold at $298.50 to $299.15. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.